1. Update on Intravenous Fibrinolytic Therapy for Acute Myocardial Infarction 
R. Scott Wright, MD, Stephen L. Kopecky, MD, Guy S. Reeder, MD 
Mayo Clinic Proceedings 
Volume 75, Issue 11, Pages (November 2000)
DOI: /
Copyright © 2000 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure 1
Thrombolytic guidelines for patients with acute myocardial infarction. BP = blood pressure; H/O = history of; LBBB = left bundle branch block; NTG = nitroglycerin; SL = sublingual.
Mayo Clinic Proceedings  , DOI: ( / )
Copyright © 2000 Mayo Foundation for Medical Education and Research Terms and Conditions

3. Figure 2
Choice of thrombolytic drug based on patient risk factors. CABO = coronary artery bypass grafting; CV = cardiovascular; ECO = electrocardiogram; Hx =history; Int = intermediate; MI = myocardial infarction; SK = streptokinase; TNK-tPA = tenecteplase. Alteplase is the trade name for recombinant tissue-type plasminogen activator (t-PA). Rales >1/3 means that rales were present in greater than one third of the lung field.
Mayo Clinic Proceedings  , DOI: ( / )
Copyright © 2000 Mayo Foundation for Medical Education and Research Terms and Conditions